Source: Skilled Nursing News

Romark Laboratories, L.C: Drugmaker Romark Seeks Nursing Home Residents for COVID-19 Clinical Trial

A U.S. pharmaceutical company is attempting to build out a full clinical trial for a drug that could potentially prevent COVID-19 infections - among other viral ailments - in long-term care settings. The Tampa, Fla.-based Romark Laboratories has high hopes for its NT-300 drug, an existing oral medication that works by preventing a virus from [...] The post Drugmaker Romark Seeks Nursing Home Residents for COVID-19 Clinical Trial appeared first on Skilled Nursing News.

Read full article »
Est. Annual Revenue
$100K-5.0M
Est. Employees
25-100
Marc S. Ayers's photo - President & CEO of Romark Laboratories, L.C

President & CEO

Marc S. Ayers

CEO Approval Rating

63/100

Read more